Gene · 79813
NIH grants1,962
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,962
Download this page as JSON| Grant | Title | EHMT1 papers | Newest fiscal year |
|---|---|---|---|
| R01MH122692 | Sex-dependent role of 5HT1A receptors in adult neurogenesis and hippocampal function | 1 | 2024 |
| R01NS111997 | A Mass Spectrometry Approach to the Genetic and Epigenetic Mechanisms Controlling Neuronal Identity | 1 | 2024 |
| R01NS114551 | The cis-regulatory grammar and epigenetic control of human interneuron progenitor specification | 1 | 2024 |
| R01NS115126 | Neuronal antigen surveillance and autoimmunity in CNS demyelinating disease | 1 | 2024 |
| R25GM121212 | UIC Portal to Biomedical Research Careers PREP (UIC PBRC-PREP) | 1 | 2024 |
| R25MD007607 | Hispanic Clinical and Translational Research Education and Career Development Program | 1 | 2024 |
| R35CA232097 | Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance | 1 | 2024 |
| R35GM137798 | Deciphering the chromatin-based DNA damage response pathway | 1 | 2024 |
| R35GM138353 | Machine Learning for Integrative Modeling of the Immune System in Clinical Settings | 1 | 2024 |
| R35GM138386 | Investigating histone glycation as a new dynamic epigenetic mark | 1 | 2024 |
| R35HL140018 | Cardiac lineage determination and nuclear architecture | 1 | 2024 |
| R50CA251961 | Translational science specialist in genitourinary cancers | 1 | 2024 |
| RC2DK120535 | Molecular Circuits in the Hematopoietic Stem Cell Niche | 1 | 2024 |
| T32GM007267 | Medical Scientist Training Program | 1 | 2024 |
| U01CA243004 | Multiscale analysis of metabolic inflammation as a driver of breast cancer | 1 | 2024 |
| U01HL098162 | Congenital Heart Disease Genetics and Clinical Outcomes | 1 | 2024 |
| U19AG063720 | The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age | 1 | 2024 |
| U54CA254564 | Innovations for screening and prognosis in HIV+ cancers including Kaposi sarcoma, cervical cancer, and lymphoma in Malawi and South Africa | 1 | 2024 |
| UH3CA261067 | Optimizing the use of ketamine to reduce chronic postsurgical pain | 1 | 2024 |
| UL1TR001412 | University of Buffalo Clinical and Translational Science Institute | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/grants?page=23